- •Visual Prosthetics
- •Preface
- •Acknowledgments
- •Contents
- •Contributors
- •1.1 The Visual System as an Engineering Compromise
- •1.2 An Overview of Human Visual System Architecture
- •1.2.1 Architecture and Basic Function of the Eye
- •1.2.2 Layout of the Retino-Cortical Pathway
- •1.2.3 Layout of the Subcortical Pathways
- •1.3 An Overview of Human Visual Function
- •1.3.1 Roles of Central (Foveal) Vision
- •1.3.2 Roles of Peripheral Vision
- •1.3.3 Roles of Dark-Adapted Vision
- •1.3.4 A Few Remarks Regarding Visual Development
- •1.4 Prospects for Prosthetic Vision Restoration
- •References
- •2.1 Introduction
- •2.2 Retina
- •2.2.1 Anatomy
- •2.2.2 Physiology and Receptive Fields
- •2.4.1 Anatomy
- •2.4.2 Physiology and Receptive Fields
- •2.6 The Role of Spatiotemporal Edges in Early Vision
- •2.7 The Role of Corners in Early Vision
- •2.7.1 Overview
- •2.8 Effects of Fixational Eye Movements in Early Visual Physiology and Perception
- •2.8.1 Overview
- •2.8.2 Neural Adaptation and Visual Fading
- •2.8.3 Microsaccades in Visual Physiology and Perception
- •References
- •3.1 Introduction
- •3.2 Background
- •3.3 Retinal Disease and Its Diversity
- •3.4 Retinal Remodeling
- •3.5 Retinal Circuitry
- •3.6 Retinal Circuitry Revision
- •3.7 Implications for Bionic Rescue
- •3.8 Implications for Biological Rescue
- •3.9 Final Remarks
- •References
- •4.1 Introduction
- •4.4 What Are the Limits to This Cortical Plasticity?
- •4.5 Possible Mechanisms Behind Brain Plasticity
- •4.6 Modulation of Brain Plasticity: Recent Developments
- •4.7 Neuroplasticity and Other Neuroprostheses Efforts
- •4.8 A Look at What Is Ahead
- •References
- •5.1 Introduction
- •5.2 Vision Changes Experienced by RP Patients
- •5.2.1 Overview
- •5.2.2 Visual Field Loss in RP
- •5.2.3 Changes in Color Vision and Glare Sensitivity in RP
- •5.2.4 Vision Fluctuations in RP
- •5.3 Visual Changes in Patients with Advanced Macular Degeneration
- •5.3.1 Changes Due to Wet AMD or Choroidal Neovascularization
- •5.3.2 Changes Due to Dry AMD or Geographic Atrophy
- •5.4 Charles Bonnet Syndrome
- •5.4.1 Overview
- •5.4.2 Complexity of Visual Hallucinations in CBS
- •5.4.3 Predictors and Alleviating Factors for CBS
- •5.5 Filling-In Phenomena (Perceptual Completion)
- •5.6 Remapping of Primary Visual Cortex in Patients with Central Scotomas from Macular Disease
- •5.7 The Preferred Retinal Locus for Fixation
- •5.8 Photopsias
- •5.8.1 Photopsias in RP
- •5.8.2 Photopsias in AMD and Other Ocular Diseases
- •5.9 Concluding Remarks
- •References
- •6.1 Introduction
- •6.2 Electrode–Electrolyte Interface
- •6.3 Electrode Material
- •6.3.1 Electrode Characterization
- •6.4 Overview of Electrode Materials for Neural Stimulation
- •6.5 Overview of Extracellular Stimulation
- •6.6 Safe Stimulation of Tissue
- •6.6.1 Mechanisms of Neural Injury
- •6.6.2 Parameters for Safe Stimulation
- •6.6.3 Stimulation Induced Injury in the Retina
- •References
- •7.1 Introduction
- •7.2 Power and Data Transmission
- •7.2.1 Wireline Connection
- •7.2.2 Inductive Coils
- •7.2.3 Serial Optical Telemetry
- •7.2.4 Photodiode Array-Based Prostheses
- •7.2.5 Thermal Safety Considerations
- •7.2.6 Conclusions: Comparing the Different Approaches
- •7.3 Tissue Response to a Subretinal Implant
- •7.3.1 Flat Implants
- •7.3.2 Chamber Implants
- •7.3.3 Pillar Arrays
- •7.4 Damage to Retinal Tissue from Electrical Stimulation
- •7.4.1 Effect of Pulse Duration
- •7.4.2 Electrode Size
- •7.5 Concluding Remarks
- •References
- •8.1 Introduction
- •8.2 Quasistatic Numerical Methods: The Admittance Method
- •8.2.1 Layered Retinal Model
- •8.2.2 Equivalent Electric Circuit
- •8.3 Three-Dimensional Activation Function Calculation
- •8.4 Safety of Implant
- •8.5 Conclusion
- •References
- •9.1 Pathophysiology of Retinal Degeneration
- •9.2.1 Outer Plexiform Layer
- •9.2.2 Inner Plexiform Layer
- •9.2.2.1 Bipolar Cell Excitation of Retinal Ganglion Cells
- •9.2.2.2 Amacrine Cell Modulation of Signal Processing
- •9.2.2.3 Inhibitory Transmitters
- •9.2.2.4 Acetylcholine and Dopamine
- •9.2.2.5 Neuropeptides
- •9.2.2.6 Putative neurotransmitters for retinal prosthesis
- •9.3 Neurophysiological Changes in Retinal Degeneration
- •9.4 Rationale for a Neurotransmitter-Based Retinal Prosthesis
- •9.4.1 Limitations of Electrical Stimulation
- •9.5 Technical Considerations and Design Approaches
- •9.5.1 Operating Principles for a Neurotransmitter-Based Retinal Prosthesis
- •9.5.2 Establishing a Retinal Prosthesis/Synaptic Interface
- •9.5.2.1 The Proximity Requirement
- •9.5.2.2 Convective Delivery of Neurotransmitters Via Microfluidics
- •9.5.2.3 Functionalized Surfaces for Neurotransmitter Stimulation
- •9.5.2.4 Synaptic Requirements for l-Glutamate Mediated Neuronal Stimulation
- •9.6 Summary
- •References
- •10.1 Introduction
- •10.2 Pioneering Experiments
- •10.2.1 Stimulation with No Chromophores
- •10.2.2 Azo Chromophores
- •10.3 Current Research
- •10.3.1 Caged Neurotransmitters
- •10.3.2 Pore Blocker and Photoisomerization
- •10.3.3 The Channelrhodopsins
- •10.3.4 Melanopsin
- •10.4 Synthetic Chromophores and Artificial Sight
- •References
- •11.1 Background
- •11.2 Physical Structure of Intracortical Electrodes
- •11.3 Charge Injection Using Intracortical Electrodes
- •11.3.1 The Intracortical Electrode as a Transducer
- •11.3.2 Charge Injection Limits
- •11.4 Intracortical Electrode Coatings
- •11.5 Characterization of Intracortical Electrodes
- •11.5.1 Cyclic Voltammetry
- •11.5.2 Electrode Stimulation Voltage Waveforms
- •11.5.3 Non-ideal Access Resistance Behavior
- •11.5.4 Non-linear Electrode Polarization
- •11.5.5 Determining Electrode Safety
- •11.6 Contrasts of In Vitro and In Vivo Behavior
- •11.7 Alternative Coatings for Improving Intracortical Electrodes
- •11.7.1 SIROF
- •11.7.2 PEDOT
- •11.7.3 Carbon Nanotube Coatings
- •11.8 Conclusion
- •References
- •12.1 Introduction
- •12.2 Responses of RGCs to Electrical Stimulation in Normal Retina
- •12.2.1 Epiretinal Stimulation
- •12.2.1.1 Target of Stimulation
- •12.2.1.2 The Site of Spike Initiation in RGCs
- •12.2.1.3 Threshold vs. Stimulating Electrode Diameter
- •12.2.1.4 Spatial Extent of Activation
- •12.2.1.5 Selective Activation
- •12.2.1.6 Temporal Response Properties
- •12.2.2 Subretinal Stimulation
- •12.2.2.1 Target of Stimulation
- •12.2.2.2 Threshold vs. Polarity of Stimulation Pulse
- •12.2.2.3 Spatial Extent of Activation
- •12.2.2.4 Temporal Response Properties
- •12.2.2.5 Dynamics of the Retinal Response
- •12.4 Responses of RGCs to Electrical Stimulation in Degenerate Retina
- •12.4.1 Epiretinal Stimulation
- •12.4.2 Subretinal Stimulation
- •12.4.2.1 Response Properties of RGCs
- •12.4.2.2 Activation Thresholds of RGCs
- •12.5 Cortical Responses to Retinal Stimulation
- •12.5.1 Spatial Properties Revealed by Cortical Measurements
- •12.5.2 Local Field Potentials
- •12.5.3 Elicited Responses Are Focal
- •12.5.4 Cortical Measurements Reveal Electrode Interactions
- •12.5.5 Temporal Responsiveness in Cortex
- •12.6 Suggestions for Future Studies
- •References
- •13.1 Introduction
- •13.2 General Considerations for Acute Retinal Stimulation Experiments
- •13.3 Surgical Technique
- •13.4 Threshold Measurements
- •13.5 Spatial Resolution and Pattern Perception
- •13.6 Temporal Resolution
- •13.7 Subretinal Versus Epiretinal Stimulation
- •13.8 Less Invasive Stimulation Procedures
- •13.9 Conclusions and Outlook
- •References
- •14.1 Introduction
- •14.2 Overview of Chronic Retinal Implant Technologies
- •14.2.1 The Retinal Implant AG Microphotodiode Prosthesis
- •14.2.2 The Intelligent Retinal Implant System
- •14.2.3 Second Sight Medical Products, Inc. A16 System
- •14.3 Thresholds on Individual Electrodes
- •14.3.1 Single Pulse Thresholds Using the SSMP System
- •14.3.2 Pulse Train Integration and Temporal Sensitivity
- •14.4 Suprathreshold Brightness
- •14.4.1 Brightness Using the Retinal Implant AG System
- •14.4.2 Brightness Using the Intelligent Medical Implant System
- •14.4.3 Brightness Using the SSMP A16 System
- •14.5 Spatial Vision
- •14.5.1 Spatial Vision with the Retinal Implant AG System
- •14.5.2 Spatial Vision with the Intelligent Medical Implant System
- •14.5.3 Spatial Vision with the SSMP A16 System
- •14.6 Models to Guide Electrical Stimulation Protocols
- •14.7 Conclusions
- •References
- •15.1 Background
- •15.2 Cortical Surface Stimulation
- •15.3 Intracortical Microstimulation
- •15.4 Optic Nerve Stimulation
- •15.5 What Is Known and What Needs to Be Done
- •15.6 Current Research Efforts
- •15.6.1 Optic Nerve Stimulation
- •15.6.2 Cortical Surface Stimulation
- •15.6.3 Intracortical Stimulation of Visual Cortex
- •15.6.4 CORTIVIS Program
- •15.6.5 Lateral Geniculate Stimulation
- •15.7 Microelectrode Arrays and Stimulation Hardware
- •15.7.1 Miniature Cameras
- •15.7.2 Animal Models
- •15.7.3 Image Processing and Phosphene Mapping
- •15.8 Conclusion
- •References
- •16.1 Introduction
- •16.2 Simulation Techniques and Basic Parameters
- •16.2.1 Gaze Tracking and Image Stabilization
- •16.2.2 Filter Engine Parameters
- •16.2.2.1 Raster Spatial Properties
- •16.2.2.2 Dot Spatial Properties
- •16.2.2.3 Temporal Properties
- •16.2.2.4 Dynamic Background Noise
- •16.2.2.5 Input Filtering/Windowing, Image Enhancement
- •16.3 Optotype Resolution and Reading
- •16.3.1 Visual Acuity
- •16.3.2 Reading
- •16.4 Face and Object Recognition
- •16.5 Visually Guided Behavior
- •16.5.1 Hand–Eye Coordination
- •16.5.2 Wayfinding
- •16.6 Visual Tracking
- •16.7 Computational Simulations
- •16.8 Conclusion
- •References
- •17.1 Introduction
- •17.2 Situating Image Analysis
- •17.3 The Experimental Framework
- •17.4 Tracking a Low-Resolution Target
- •17.5 Discussion
- •17.6 Conclusion
- •References
- •18.1 Introduction
- •18.2 Representation of Visual Space on the Visual Cortex
- •18.3 Cortical Stimulation Studies
- •18.4 Variability in Occipital Cortex
- •18.5 Phosphene Map Estimation
- •18.6 Psychophysical Studies with the Estimated Maps
- •References
- •19.1 Importance of Mapping
- •19.3 The Computer Era: Refining the Pointing Method of Phosphene Mapping
- •19.4 Verbal Mapping
- •19.5 Mapping Studies Using Subject Drawings
- •19.6 Recent Simulation Studies Using Phosphene Mapping
- •19.6.1 Tactile Simulations at Shanghai Jiao Tong University
- •19.6.2 Simulations in Our Laboratory
- •19.7 Concluding Remarks on Phosphene Mapping Techniques
- •References
- •20.1 Introduction
- •20.2 Principles for Assessment of Prosthetic Vision
- •20.2.1 Experimental Design
- •20.2.2 The Importance of Pre-operative Testing
- •20.2.3 Post-operative Assessment
- •20.2.4.1 Potential Approaches
- •20.2.4.2 Avoidance of Bias
- •20.2.4.3 Criteria for Sound Testing
- •20.2.4.4 Forced Choice Procedures
- •20.2.4.5 Response Time
- •20.2.4.6 Task (Perceptual) Learning
- •20.2.4.7 Establishing Criteria for Meaningful Change
- •20.2.4.8 Light Level
- •20.3 Vision Assessment in Prosthesis Recipients: Overview
- •20.3.1 Visual Function Assessment: Overview
- •20.3.2 Visual Performance Assessment: Overview
- •20.3.2.1 Measured Visual Performance
- •20.3.2.2 Self-Reported Visual Performance
- •20.4 Visual Function Assessment
- •20.4.1 Candidate Measures
- •20.4.1.1 Contrast Sensitivity (Contrast Detection)
- •20.4.1.2 Contrast Discrimination
- •20.4.1.3 Motion Perception
- •20.4.1.4 Depth Perception
- •20.4.2 Tests Used in Prosthesis Trials
- •20.4.3 Tests that Have Been Designed for Use with Prostheses
- •20.4.4 Vision Tests for Very Low Vision
- •20.5 Visual Performance Assessment
- •20.5.1 Measured Performance
- •20.5.2 Self-Reported Performance (Questionnaires)
- •20.6 Summary
- •References
- •21.1 Concepts of Functional Vision and Rehabilitation
- •21.1.1 Application to Orientation and Mobility
- •21.1.2 Application for Activities of Daily Living
- •21.1.3 Patient Lifestyle and Expectations
- •21.1.4 Congenital and Adventitious Vision Loss
- •21.2 Evaluation and Intervention with Prosthetic Vision
- •21.2.1 Evaluation
- •21.2.2 Intervention
- •21.3 Measuring Functional Outcomes
- •21.4 The Future
- •References
- •Author Index
- •Subject Index
8 Retinal Cell Excitation Modeling |
171 |
Part of what makes solving these systems very challenging is the fact that the size of the model tends to be large in comparison with the minimum feature size, resulting in extremely large linear systems, which can only be solved by using iterative algebraic methods. In addition, the material properties and consequently the current and voltage magnitudes involved can vary multiple orders of magnitude, making the convergence of the system harder for iterative solvers. Some of the models we are currently working with involve matrices having over 50 million rows and columns. These systems are being solved using multi-resolution techniques and sparse iterative linear solvers [17, 18].
The configurations analyzed in this article considered an intraocular current return. Characterizing performance for different current return configurations in epiretinal implants is complex. Part of the issue is that biological tissue in the area is arranged in layers, and the range of conductivities involved varies by several orders of magnitude. Further, if the current return electrode is implanted extraocularly and the eye retain movement after surgery, current densities will vary with the position of the eye as well. In general, as the electrode array is pressed into the retina, the current injected tend to penetrate the retinal surface under each of the active electrodes regardless of the current return configurations. The currents injected for each electrode will then seek a path towards the current return, and any asymmetry in the conductive path from the electrode through the tissue to the current return will result in different current density patterns; areas having shadows of lower current densities will appear. This shadow effect is more pronounced with larger and denser electrode arrays, and it is hard to characterize. Some of the current return related factors that affect performance include current return shape, size, material, surrounding tissue structures, and distance.
References
1.Armitage DW, LeVeen HH, Pethig R (1983), Radiofrequency-induced hyperthermia: computer simulation of specific absorption rate distributions using realistic anatomical models. Phys Med Biol, 28(1): p. 31–42.
2.Brummer SB, Roblee LS (1983), Criteria for selecting electrodes for electrical stimulation: Theoretical and practical considerations. Ann NY Acad Sci, 405: p. 159–171.
3.Ebert M, Brown PK, Lazzi G (2003), Two-dimensional SPICE-linked multiresolution impedance method for low frequency electromagnetic interactions. IEEE Trans Biomed Eng, 50(7): p. 881–889.
4.Gabriel S, Lau RW, Gabriel C (1996), The dielectric properties of biological tissues: II
Measurements in the frequency range 10 Hz to 20 GHz. Phys Med Biol, 41(11):
p.2251–2269.
5.Gandhi OP, DeFord JF, Kanai H (1984), Impedance method for calculation of power deposition patterns in magnetically induced hyperthermia. IEEE Trans Biomed Eng, BME-31:
p.644–651.
6.Greenberg RJ, Velte TJ, Humayun MS, et al. (1999), A computational model of electrical stimulation of the retinal ganglion cell. IEEE Trans Biomed Eng, 46(5): p. 505–514.
7.Hodgkin AL, Huxley AF (1952), A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol, 117(4): p. 500–544.
172 |
C.J. Cela and G. Lazzi |
8.Humayun MS, De Juan Jr E, Weiland JD, et al. (1999), Pattern electrical stimulation of the human retina. Vision Res, 39: p. 2569–2576.
9.IEEE International Committee on Electromagnetic Safety (2005), IEEE standard for safety levels with respect to human exposure to radio frequency electromagnetic fields, 3 kHz to 300 GHz. IEEE Std C95.1.
10.International Commission for Non-Ionizing Radiation Protection (1998), Guidelines for limiting exposure to time-varying electric, magnetic, and electromagnetic fields (up to 300 GHz).
Health Phys 74: p. 494–522.
11. Karwoski CJ, Frambach DA, Proenza LM (1985), Laminar profile of resistivity in frog retina. J Neurophysiol 54(6): p. 1607–1619.
12. Mahadevappa M, Weiland JD, Yanai D, et al. (2005), Perceptual thresholds and electrode impedance in three retinal prostheses subjects. IEEE Trans Neural Syst Rehabil Eng, 13(2): p. 201–206.
13. Rattay F (1986), Analysis of models for external stimulation of axons. IEEE Trans Biomed Eng, BME-33: p. 974–978.
14. Rattay F (1989), Analysis of models for extracellular fiber stimulation. IEEE Trans Biomed Eng, BME-36(7): p. 676–682.
15. Rattay F (1991), Electrical Nerve Stimulation: Theory, Experiments and Applications. Springer, New York.
16. Rodieck RW (1988), The primate retina. Comp Primate Biol, 4: p. 203–278.
17. Schmidt S, Cela CJ, Singh V, et al. (2007), Computational modeling of electromagnetic and thermal effects for a dual-unit retinal prosthesis: inductive telemetry, temperature increase, and current densities in the retina. Artificial Sight, eds. Humayun MS, Weiland JD, Chader G, et al.: Springer, Berlin.
18. Cela CJ (2010), A Multiresolution Admittance Method for Large-Scale Bioelectromagnetic Interactions. PhD dissertation, North Carolina State University, Raleigh, NC.
Chapter 9
Neurotransmitter Stimulation for Retinal Prosthesis: The Artificial Synapse Chip
Raymond Iezzi and Paul G. Finlayson
Abstract Retinal prostheses may one day improve the lives of hundreds of thousands of patients with retinitis pigmentosa (RP) or millions of blind patients with advanced age-related macular degeneration (ARMD), depending on their effectiveness. While considerable progress has been made in electrical stimulation of the retina, herein we explore some possible alternatives to electrical stimulation for retinal prosthesis. Since neurotransmitters normally shape visual responses, some groups have been developing visual prostheses based upon the spatially and temporally controlled delivery of neurotransmitters to the retina. This chapter examines the possibilities for utilizing these chemical messengers, as a means to effectively stimulate retinal ganglion cells and produce vision along established visual information channels.
Abbreviations
5HT |
5-Hydoxytryphan, serotonin |
AGB |
1-Amino-4-guanidobutane |
AMPA |
a-Amino-3-hydroxyl-5-methyl-4-isoxazole-propionate |
EAAT |
Excitatory amino acid transporters |
GABA |
Gamma-aminobutyrate |
iGluR |
Ionotropic glutamate receptor (GluR1, GluR2, GluR3, GluR4) |
INL |
Inner nuclear layer |
IPL |
Inner plexiform layer |
mGlur |
Metabotropic glutamate receptor |
NMDA |
N-methyl-D-aspartate |
OPL |
Outer plexiform layer |
P# |
Postnatal day |
PR |
Photoreceptors |
R. Iezzi (*)
Department of Ophthalmology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA
e-mail: iezzi.raymond@mayo.edu
G. Dagnelie (ed.), Visual Prosthetics: Physiology, Bioengineering, Rehabilitation, |
173 |
DOI 10.1007/978-1-4419-0754-7_9, © Springer Science+Business Media, LLC 2011 |
|
174 |
R. Iezzi and P.G. Finlayson |
RCS |
Royal College of Surgeons |
RD1 |
Retinal degeneration type 1 mouse |
RGC |
Retinal ganglion cell |
RP |
Retinitis pigmentosa |
S334ter |
Opsin gene bearing a termination codon at residue 334 |
9.1 Pathophysiology of Retinal Degeneration
Two major classes of retinal disorders, retinitis pigmentosa and age-related macular degeneration, result in the loss of vision, due to progressive loss of photoreceptors (PR). Retinitis pigmentosa is a term used to designate diverse genetic disorders [15, 34, 38, 64] that vary in their hereditary linkage – autosomal recessive, autosomal dominant, sex linked, mitochondrial or digenic, and in the underlying genetic mutations (see Chap. 3). Although, the onset, rate and type of PR loss vary between these genetic deficits, they all result in a progressive loss of photoreceptors. It also appears that several different factors, including genetic mutations play a role in PR degeneration in ARMD [14, 33, 56, 67] (see also Chap. 3). The diverse etiologies of RP and ARMD suggest that a single treatment will likely not be possible. Animal models of retinitis pigmentosa indicate that although further neurodegeneration and reorganization in the remaining neural retina occurs (see below), much of the rich network within the retina remains intact for extended periods of time. This presents the opportunity to produce visual sensations through the artificial stimulation of the degenerated retina.
9.2 Modes of Interneuronal Communication
Within the Normal Retina
Although, excitatory (glutamate) and inhibitory (GABA and glycine) amino acids are the major neurotransmitter systems in the retina, other transmitters, including acetylcholine, serotonin, dopamine and a variety of neuropeptides shape the visual response (Table 9.1). There is a large diversity of receptors on retinal cell somata and dendrites in the inner and outer plexiform layers (IPL and OPL) and retinal ganglion cell layer (Table 9.2). The outer and inner plexiform layers are near enough to the subretinal and epiretinal surfaces, respectively, for effective activation by application of exogenous agents. In addition, the diversity and location of receptors may allow for differential stimulation of pathways, such as OFF and ON.
